Foresite Capital Management VI »

Zura Bio shares owned by Foresite Capital Management VI

Quarter-by-quarter ownership of Zura Bio (ZURA) shares owned by Foresite Capital Management VI from 13F filings

Historical chart of Foresite Capital Management VI investment in Zura Bio

Tip: Access up to 7 years of quarterly data

All positions including Zura Bio held by Foresite Capital Management VI consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zura Bio by Foresite Capital Management VI

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.7M 450k 5.95

More positions owned by Foresite Capital Management VI

Cg Oncology (CGON)
Alumis (ALMS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Corvus Pharmaceuticals (CRVS)
Denali Therapeutics (DNLI)
Agios Pharmaceuticals (AGIO)
Verastem (VSTM)
Kymera Therapeutics (KYMR)
Minerva Neurosciences (NERV)
Celldex Therapeutics (CLDX)
Ataibeckley (ATAI)
Hinge Health Cl A (HNGE)
Crinetics Pharmaceuticals In (CRNX)
OnKure Therapeutics Com Cl A (OKUR)
Jade Biosciences (JBIO)

View all positions for Foresite Capital Management VI

Top funds holding Zura Bio

Suvretta Capital Management
VR Adviser
Dr. Jeffrey R. Jay, M.D.
Braidwell
Commodore Capital
Pfizer
Adage Capital Partners GP
Affinity Asset Advisors
Millennium Management
Armistice Capital
Cormorant Asset Management
QVT Financial
Siren
Ikarian Capital
EcoR1 Capital

View all funds holding Zura Bio